PRQR logo

ProQR Therapeutics NV (PRQR) Selling, General & Administrative Expenses

Annual SGA

$17.58 M
-$2.09 M-10.64%

December 31, 2023

Summary

Performance

1-Year Change

-10.64%

3-Year Change

+12.47%

5-Year Change

+18.71%

15-Year Change

+43.18%

PRQR SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.2%
PRQR annual SGA is higher than 37.2% of companies in Healthcare sector

High & Low

All-time High

$20.55 M
PRQR annual SGA is currently -14.46% below its historical high of $20.55 million

3-Year Low

$17.58 M
PRQR annual SGA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
PRQR previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 13, 2025
PRQR next annual earnings announcement is scheduled for Mar 13, 2025

OtherPRQRexpensesmetrics:

Annual Total Expenses

$44.72 M
PRQR annual total expenses is $44.72 million

Annual Operating Expenses

$44.72 M
PRQR annual total operating expenses is $44.72 million

Annual Cost Of Goods Sold

-
PRQR annual cost of goods sold value is unknown

Annual Interest Expense

$1.30 M
PRQR annual interest expense is $1.30 million

Quarterly SGA

$3.61 M
+$366.50 K+11.30%

September 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

-33.12%

5-Year Change

-33.12%

PRQR Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

30.25%
PRQR quarterly SGA is higher than 30.25% of companies in Healthcare sector

High & Low

All-time High

$6.08 M
PRQR quarterly SGA is currently -40.61% below its historical high of $6.08 million

3-Year Low

$3.04 M
PRQR quarterly SGA is currently +18.82% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
PRQR previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
PRQR next earnings announcement is scheduled for Mar 13, 2025

OtherPRQRexpensesmetrics:

Quarterly Total Expenses

$13.96 M
PRQR quarterly total expenses is $13.96 million

Quarterly Operating Expenses

$13.96 M
PRQR quarterly total operating expenses is $13.96 million

Quarterly Cost Of Goods Sold

-
PRQR quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
PRQR quarterly interest expense value is unknown

TTM SGA

-$1.79 B
-$48.01 M-2.75%

September 1, 2024

Summary

Performance

3-Month Change

-11492.49%

1-Year Change

-11492.49%

3-Year Change

-7971.76%

5-Year Change

-7971.76%

PRQR TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

27.6%
PRQR TTM SGA is higher than 27.6% of companies in Healthcare sector

High & Low

All-time High

-$5.07 M

3-Year Low

-$1.79 B
PRQR TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
PRQR previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
PRQR next earnings announcement is scheduled for Mar 13, 2025

OtherPRQRexpensesmetrics:

Annual Total Expenses

$44.72 M
PRQR annual total expenses is $44.72 million

Annual Operating Expenses

$44.72 M
PRQR annual total operating expenses is $44.72 million

TTM Cost Of Goods Sold

-
PRQR TTM cost of goods sold value is unknown

TTM Interest Expense

-
PRQR TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$17.58 M
PRQR annual SGA is $17.58 million

Annual Operating Expenses

$44.72 M
PRQR annual total operating expenses is $44.72 million

Annual Cost Of Goods Sold

-
PRQR annual cost of goods sold value is unknown

PRQR Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-10.6%0.0%-10000.0%
3 y3 years+12.5%-33.1%-7971.8%
5 y5 years+18.7%-33.1%-7971.8%

PRQR Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-14.5%at low-40.6%+18.8%-153.1%at low
5 y5-year-14.5%+21.8%-40.6%+18.8%-169.3%at low
alltimeall time-14.5%+1583.8%-40.6%+1289.8%<-9999.0%at low

ProQR Therapeutics NV Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$3.61 M(+11.3%)
$15.72 M(+0.0%)
Jun 2024
-
$3.24 M(-13.5%)
$15.72 M(-7.5%)
Mar 2024
-
$3.75 M(-26.7%)
$16.99 M(-3.3%)
Dec 2023
$17.58 M(-10.6%)
$5.12 M(+41.7%)
$17.57 M(+13.4%)
Sep 2023
-
$3.61 M(-20.1%)
$15.49 M(-10.4%)
Jun 2023
-
$4.52 M(+4.5%)
$17.28 M(-6.7%)
Mar 2023
-
$4.32 M(+42.3%)
$18.53 M(-6.0%)
Dec 2022
$19.67 M(-4.3%)
$3.04 M(-43.7%)
$19.71 M(-13.4%)
Sep 2022
-
$5.40 M(-6.4%)
$22.75 M(-0.1%)
Jun 2022
-
$5.76 M(+4.7%)
$22.77 M(+3.6%)
Mar 2022
-
$5.51 M(-9.4%)
$21.97 M(+7.2%)
Dec 2021
$20.55 M(+31.5%)
$6.08 M(+12.3%)
$20.48 M(+10.2%)
Sep 2021
-
$5.41 M(+9.0%)
$18.59 M(+12.9%)
Jun 2021
-
$4.97 M(+23.5%)
$16.46 M(+7.7%)
Mar 2021
-
$4.02 M(-3.9%)
$15.29 M(-1.9%)
Dec 2020
$15.63 M(+8.3%)
$4.19 M(+27.5%)
$15.59 M(-1.0%)
Sep 2020
-
$3.28 M(-13.4%)
$15.74 M(+0.4%)
Jun 2020
-
$3.80 M(-12.2%)
$15.68 M(+3.7%)
Mar 2020
-
$4.32 M(-0.3%)
$15.12 M(+4.8%)
Dec 2019
$14.43 M
$4.34 M(+34.4%)
$14.42 M(-6.2%)
Sep 2019
-
$3.23 M(-0.1%)
$15.38 M(+1.5%)
Jun 2019
-
$3.23 M(-10.9%)
$15.15 M(+0.5%)
DateAnnualQuarterlyTTM
Mar 2019
-
$3.62 M(-31.5%)
$15.08 M(+2.3%)
Dec 2018
$14.81 M(+20.6%)
$5.29 M(+76.5%)
$14.74 M(+14.7%)
Sep 2018
-
$3.00 M(-5.2%)
$12.85 M(-1.8%)
Jun 2018
-
$3.16 M(-3.6%)
$13.09 M(-0.1%)
Mar 2018
-
$3.28 M(-3.6%)
$13.11 M(+6.7%)
Dec 2017
$12.28 M(+17.0%)
$3.40 M(+5.2%)
$12.28 M(+8.5%)
Sep 2017
-
$3.24 M(+1.7%)
$11.31 M(+9.7%)
Jun 2017
-
$3.18 M(+29.6%)
$10.31 M(+2.3%)
Mar 2017
-
$2.45 M(+0.7%)
$10.08 M(-4.0%)
Dec 2016
$10.49 M(+38.3%)
$2.44 M(+9.2%)
$10.50 M(+2.4%)
Sep 2016
-
$2.23 M(-24.4%)
$10.25 M(+6.4%)
Jun 2016
-
$2.95 M(+2.9%)
$9.63 M(+11.5%)
Mar 2016
-
$2.87 M(+31.2%)
$8.64 M(+14.0%)
Dec 2015
$7.59 M(-12.3%)
$2.19 M(+35.0%)
$7.58 M(-3.9%)
Sep 2015
-
$1.62 M(-17.5%)
$7.89 M(-16.3%)
Jun 2015
-
$1.96 M(+8.6%)
$9.42 M(-1.5%)
Mar 2015
-
$1.81 M(-27.5%)
$9.56 M(+11.6%)
Dec 2014
$8.65 M(+728.9%)
$2.49 M(-20.9%)
$8.57 M(+30.9%)
Sep 2014
-
$3.15 M(+49.8%)
$6.55 M(+79.3%)
Jun 2014
-
$2.11 M(+158.3%)
$3.65 M(+136.2%)
Mar 2014
-
$815.20 K(+73.1%)
$1.55 M(+111.5%)
Dec 2013
$1.04 M
$471.00 K(+81.3%)
$730.80 K(+181.3%)
Sep 2013
-
$259.80 K
$259.80 K

FAQ

  • What is ProQR Therapeutics NV annual SGA?
  • What is the all time high annual SGA for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV annual SGA year-on-year change?
  • What is ProQR Therapeutics NV quarterly SGA?
  • What is the all time high quarterly SGA for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV quarterly SGA year-on-year change?
  • What is ProQR Therapeutics NV TTM SGA?
  • What is the all time high TTM SGA for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV TTM SGA year-on-year change?

What is ProQR Therapeutics NV annual SGA?

The current annual SGA of PRQR is $17.58 M

What is the all time high annual SGA for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high annual SGA is $20.55 M

What is ProQR Therapeutics NV annual SGA year-on-year change?

Over the past year, PRQR annual SGA has changed by -$2.09 M (-10.64%)

What is ProQR Therapeutics NV quarterly SGA?

The current quarterly SGA of PRQR is $3.61 M

What is the all time high quarterly SGA for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high quarterly SGA is $6.08 M

What is ProQR Therapeutics NV quarterly SGA year-on-year change?

Over the past year, PRQR quarterly SGA has changed by $0.00 (0.00%)

What is ProQR Therapeutics NV TTM SGA?

The current TTM SGA of PRQR is -$1.79 B

What is the all time high TTM SGA for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high TTM SGA is -$5.07 M

What is ProQR Therapeutics NV TTM SGA year-on-year change?

Over the past year, PRQR TTM SGA has changed by -$1.81 B (-11492.49%)